Betta Pharmaceuticals Co. Ltd Financials

Market Capitalization CN¥20.57 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	64.85
Forward PE	27.79
Price to Sales TTM	CN¥6.02
Price to Book MRQ	CN¥3.36
Enterprise to Revenue	6.64
Enterprise to EBITDA	23.00

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	9.29%
Operating Margin	20.21%
Return on Assets TTM	3.43%
Return on Equity TTM	4.89%

Income Statement

Revenue TTM	CN¥3,264,649,728
Revenue per Share TTM	CN¥7.83
Quarterly Revenue Growth	16.80%
Gross Profit TTM	CN¥2,571,495,936
EBITDA	CN¥515,977,253
Net Income to Common TTM	CN¥303,275,776
Diluted EPS TTM	CN¥0.72
Quarterly Earnings Growth YoY	-7.90%

Balance Sheet

Total Cash MRQ	CN¥491,930,112
Total Cash per Share MRQ	CN¥1.17
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	41.56
Current Ratio MRQ	0.77
Book Value per Share MRQ	CN¥13.89

Cash Flow

Operating Cash Flow TTM	CN¥748,261,696
Levered Free Cash Flow TTM	CN¥-395,064,960

300558 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	420,733,843
Float Shares	233,549,356
Avg 10 Volume	3,596,735
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	43.78%
% Held by Institutions	13.87%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	CN¥45.25
Fifty Two Week High	CN¥79.80
Fifty Two Week Change	-13.67%
Day 50 MA	CN¥50.66
Day 200 MA	CN¥57.88

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	1.70%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	0.43%
Payout Ratio	27.63%
Dividend Date
Ex Dividend Date	2025-06-17
Last Split Factor
Last Split Date